The Gateway Pundit By Jim Hoft
The Malaysian Health Ministry announced that it has recorded 25 cases of myocarditis in patients within 21 days after receiving COVID-19 vaccines from February to September 2021. This comes after a group of doctors in Malaysia raised concern about the risk of young adults developing myocarditis and pericarditis from the experimental COVID-19 vaccines.
Out of 25 cases, 14 cases of myocarditis were linked to the Pfizer-BioNTech Covid-19 vaccine, 9 cases were linked to Sinovac (CoronaVac), and 2 were AstraZeneca vaccine recipients.
Yahoo Malaysia reported:
In a statement, the ministry explained that the NPRAâs reporting format would signal health professionals to any potential side effects or concerns for the safety of the vaccine, and that the government is fully committed to its continuous monitoring of the ongoing vaccination programme.
